Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
59%
Total
Publications
140
Total Open
Publications
83
Total
Citations
5.6K
Open Access
Percentage
59%
Total
Publications
140
Total Open
Publications
83
Total
Citations
5.6K
Breakdown
Publisher Open
11%
Both
34%
Other Platform Open
14%
Closed
41%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 32%
20
Hybrid 41%
26
No Guarantees 27%
17
Other Platform Open
Domain 90%
61
Institution 19%
13
Public 16%
11
Other Internet 7%
5
Preprint 4%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 60 |
Europe PMC | Domain | 46 |
Semantic Scholar | Public | 11 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 4 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 3 |
bioRxiv | Preprint | 3 |
University of Oslo - Duo Research Archive | Institution | 2 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 2 |
University of California - eScholarship University of California | Institution | 2 |
University College London - UCL Discovery | Institution | 2 |